LADENBURG THALMANN FINANCIAL SERVICES INC. - STEMLINE THERAPEUTICS INC ownership

STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 62 filers reported holding STEMLINE THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of STEMLINE THERAPEUTICS INC
ValueSharesWeighting
Q4 2019$2,0000.0%1800.0%0.00%
Q3 2019$2,000
+100.0%
180
+125.0%
0.00%
Q2 2019$1,0000.0%800.0%0.00%
Q1 2019$1,0000.0%800.0%0.00%
Q4 2018$1,0000.0%800.0%0.00%
Q3 2018$1,000
-85.7%
80
-83.1%
0.00%
Q2 2018$7,0000.0%4740.0%0.00%
Q1 2018$7,000
-95.6%
474
-95.4%
0.00%
-100.0%
Q4 2017$160,000
+33.3%
10,274
-4.6%
0.00%
+100.0%
Q3 2017$120,000
+2.6%
10,774
-15.1%
0.00%0.0%
Q2 2017$117,000
+7.3%
12,6940.0%0.00%0.0%
Q1 2017$109,000
-19.9%
12,6940.0%0.00%
-50.0%
Q4 2016$136,000
+806.7%
12,694
+810.6%
0.00%
Q3 2016$15,000
+66.7%
1,3940.0%0.00%
Q2 2016$9,000
+50.0%
1,3940.0%0.00%
Q1 2016$6,000
-33.3%
1,3940.0%0.00%
Q4 2015$9,000
-25.0%
1,3940.0%0.00%
Q3 2015$12,000
-25.0%
1,3940.0%0.00%
Q2 2015$16,000
+14.3%
1,394
+39.4%
0.00%
Q1 2015$14,000
-17.6%
1,0000.0%0.00%
Q4 2014$17,000
+41.7%
1,0000.0%0.00%
Q3 2014$12,000
-20.0%
1,0000.0%0.00%
Q2 2014$15,0001,0000.00%
Other shareholders
STEMLINE THERAPEUTICS INC shareholders Q3 2015
NameSharesValueWeighting ↓
Lyon Street Capital, LLC 762,941$7,248,0007.29%
NEXTHERA CAPITAL LP 711,558$6,760,0002.79%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 585,930$4,366,0002.71%
Consonance Capital Management LP 1,155,793$10,980,0000.81%
Pier Capital, LLC 423,667$4,025,0000.80%
KNOTT DAVID M 155,795$1,480,0000.70%
Eventide Asset Management 1,086,400$10,321,0000.46%
Empire Life Investments Inc. 373,863$3,552,0000.32%
Telemetry Investments, L.L.C. 41,588$395,0000.25%
Polar Capital LLP 2,302,666$21,875,0000.23%
View complete list of STEMLINE THERAPEUTICS INC shareholders